News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2026 Caitlin E. Cox February 02, 2026
News Conference News AHA 2025 Oral PCSK9 Inhibitor Enlicitide Cuts LDL Cholesterol: CORALreef Lipids Michael O'Riordan November 10, 2025
Presentation TCT 2025 Optimizing PCI Outcomes After ACS: Lipid Modification Therapies - LDL, Lp(a) and Beyond Presenter: Marc P. Bonaca October 27, 2025
Presentation TCT 2025 TCT 758: Lp(a) and Oxidized Phospholipids as Predictors of Bioprosthetic Valve Dysfunction Following Transcatheter Aortic Valve Implantation Presenter: Frédéric Beaupré October 27, 2025
Presentation TCT 2025 TCT 471: Pericoronary Fat Attenuation Index Combined with Lp(a) for Predicting Post-PCI Adverse Outcomes in Coronary Artery Disease Patients Presenter: Zixiang Ye October 27, 2025
Presentation TCT 2025 ACS Pharma Trials On The Horizon: Other Lipid Targets - Lpa and CETP Inhibitors Presenter: Dharam J. Kumbhani October 26, 2025
News Daily News Biomarkers Added to a Polygenic Risk Score Equals Better CAD Prediction Yael L. Maxwell October 23, 2025
News Conference News ESC 2025 ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients Michael O'Riordan September 10, 2025
News Conference News SCCT 2025 Adding Coronary CT Angiography to Annual Firefighter Physicals Could Save Lives Yael L. Maxwell July 18, 2025
News Daily News PREVENT Risk Calculator Works Well in Patients With High and Low Lp(a) Michael O'Riordan June 10, 2025
News Conference News EAS 2025 Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM Yael L. Maxwell May 08, 2025
News Daily News Lp(a) Genetics Differ Between Populations but Have Similar Clinical Impact Yael L. Maxwell May 05, 2025
News Daily News Topline Data Point to Promise for VERVE-102 Gene-Editing Therapy Caitlin E. Cox April 14, 2025
News Conference News ACC 2025 ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a) L.A. McKeown April 10, 2025